 | • レポートコード：QYR9ST02366 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の中枢神経系疾患治薬市場について調査・分析し、以下の構成でお届け致します。中枢神経系疾患治薬の種類別には、OTC、処方薬に、用途別には、病院、小売薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別中枢神経系疾患治薬売上データ ・地域別中枢神経系疾患治薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別中枢神経系疾患治薬市場規模：OTC、処方薬 ・用途別中枢神経系疾患治薬市場規模：病院、小売薬局 ・主要メーカーの企業情報：Biogen、Pfizer、Teva、Novartis、Johnson & Johnson、Eli Lilly 、Otsuka、Merck、AstraZeneca、Novartis、Shire ・中枢神経系疾患治薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease.The global Central Nervous System Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Central Nervous System Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Central Nervous System Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Central Nervous System Drugs in these regions.
This research report categorizes the global Central Nervous System Drugs market by top players/brands, region, type and end user. This report also studies the global Central Nervous System Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
Eli Lilly
Otsuka
Merck
AstraZeneca
Novartis
Shire
Market size by Product
OTC
Rx Drugs
Market size by End User
Hospital
Retail Pharmacy
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Central Nervous System Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Central Nervous System Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Central Nervous System Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Central Nervous System Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Central Nervous System Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Central Nervous System Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Central Nervous System Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Central Nervous System Drugs Market Size Growth Rate by Product
1.4.2 OTC
1.4.3 Rx Drugs
1.5 Market by End User
1.5.1 Global Central Nervous System Drugs Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Retail Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Central Nervous System Drugs Market Size
2.1.1 Global Central Nervous System Drugs Revenue 2014-2025
2.1.2 Global Central Nervous System Drugs Sales 2014-2025
2.2 Central Nervous System Drugs Growth Rate by Regions
2.2.1 Global Central Nervous System Drugs Sales by Regions
2.2.2 Global Central Nervous System Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Central Nervous System Drugs Sales by Manufacturers
3.1.1 Central Nervous System Drugs Sales by Manufacturers
3.1.2 Central Nervous System Drugs Sales Market Share by Manufacturers
3.1.3 Global Central Nervous System Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Central Nervous System Drugs Revenue by Manufacturers
3.2.1 Central Nervous System Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Central Nervous System Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Central Nervous System Drugs Price by Manufacturers
3.4 Central Nervous System Drugs Manufacturing Base Distribution, Product Types
3.4.1 Central Nervous System Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Central Nervous System Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Central Nervous System Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Central Nervous System Drugs Sales by Product
4.2 Global Central Nervous System Drugs Revenue by Product
4.3 Central Nervous System Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Central Nervous System Drugs Breakdown Data by End User
6 North America
6.1 North America Central Nervous System Drugs by Countries
6.1.1 North America Central Nervous System Drugs Sales by Countries
6.1.2 North America Central Nervous System Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Central Nervous System Drugs by Product
6.3 North America Central Nervous System Drugs by End User
7 Europe
7.1 Europe Central Nervous System Drugs by Countries
7.1.1 Europe Central Nervous System Drugs Sales by Countries
7.1.2 Europe Central Nervous System Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Central Nervous System Drugs by Product
7.3 Europe Central Nervous System Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Central Nervous System Drugs by Countries
8.1.1 Asia Pacific Central Nervous System Drugs Sales by Countries
8.1.2 Asia Pacific Central Nervous System Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Central Nervous System Drugs by Product
8.3 Asia Pacific Central Nervous System Drugs by End User
9 Central & South America
9.1 Central & South America Central Nervous System Drugs by Countries
9.1.1 Central & South America Central Nervous System Drugs Sales by Countries
9.1.2 Central & South America Central Nervous System Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Central Nervous System Drugs by Product
9.3 Central & South America Central Nervous System Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Central Nervous System Drugs by Countries
10.1.1 Middle East and Africa Central Nervous System Drugs Sales by Countries
10.1.2 Middle East and Africa Central Nervous System Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Central Nervous System Drugs by Product
10.3 Middle East and Africa Central Nervous System Drugs by End User
11 Company Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Company Business Overview
11.1.3 Biogen Central Nervous System Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Biogen Central Nervous System Drugs Products Offered
11.1.5 Biogen Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Central Nervous System Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Central Nervous System Drugs Products Offered
11.2.5 Pfizer Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Company Business Overview
11.3.3 Teva Central Nervous System Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Teva Central Nervous System Drugs Products Offered
11.3.5 Teva Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Company Business Overview
11.4.3 Novartis Central Nervous System Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis Central Nervous System Drugs Products Offered
11.4.5 Novartis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Company Business Overview
11.5.3 Johnson & Johnson Central Nervous System Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Johnson & Johnson Central Nervous System Drugs Products Offered
11.5.5 Johnson & Johnson Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Company Business Overview
11.6.3 Eli Lilly Central Nervous System Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Eli Lilly Central Nervous System Drugs Products Offered
11.6.5 Eli Lilly Recent Development
11.7 Otsuka
11.7.1 Otsuka Company Details
11.7.2 Company Business Overview
11.7.3 Otsuka Central Nervous System Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Otsuka Central Nervous System Drugs Products Offered
11.7.5 Otsuka Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Company Business Overview
11.8.3 Merck Central Nervous System Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Merck Central Nervous System Drugs Products Offered
11.8.5 Merck Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 Company Business Overview
11.9.3 AstraZeneca Central Nervous System Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 AstraZeneca Central Nervous System Drugs Products Offered
11.9.5 AstraZeneca Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Company Business Overview
11.10.3 Novartis Central Nervous System Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Novartis Central Nervous System Drugs Products Offered
11.10.5 Novartis Recent Development
11.11 Shire
12 Future Forecast
12.1 Central Nervous System Drugs Market Forecast by Regions
12.1.1 Global Central Nervous System Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Central Nervous System Drugs Revenue Forecast by Regions 2019-2025
12.2 Central Nervous System Drugs Market Forecast by Product
12.2.1 Global Central Nervous System Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Central Nervous System Drugs Revenue Forecast by Product 2019-2025
12.3 Central Nervous System Drugs Market Forecast by End User
12.4 North America Central Nervous System Drugs Forecast
12.5 Europe Central Nervous System Drugs Forecast
12.6 Asia Pacific Central Nervous System Drugs Forecast
12.7 Central & South America Central Nervous System Drugs Forecast
12.8 Middle East and Africa Central Nervous System Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Central Nervous System Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Central Nervous System Drugs Product Picture
Table Central Nervous System Drugs Market Segments
Table Key Manufacturers Central Nervous System Drugs Covered
Table Global Central Nervous System Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Central Nervous System Drugs Sales Market Share by Product 2014-2025
Figure OTC Product Picture
Table Major Manufacturers of OTC
Figure Rx Drugs Product Picture
Table Major Manufacturers of Rx Drugs
Table Global Central Nervous System Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Retail Pharmacy
Figure Central Nervous System Drugs Report Years Considered
Figure Global Central Nervous System Drugs Market Size 2014-2025 (Million US$)
Figure Global Central Nervous System Drugs Sales 2014-2025 (K Units)
Table Global Central Nervous System Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Central Nervous System Drugs Sales by Regions 2014-2019 (K Units)
Table Global Central Nervous System Drugs Sales Market Share by Regions 2014-2019
Figure Global Central Nervous System Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Central Nervous System Drugs Sales Market Share by Regions
Table Global Central Nervous System Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Central Nervous System Drugs Revenue Market Share by Regions 2014-2019
Figure Global Central Nervous System Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Central Nervous System Drugs Revenue Market Share by Regions
Table Global Central Nervous System Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Central Nervous System Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Central Nervous System Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Central Nervous System Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Central Nervous System Drugs Revenue Share by Manufacturers (2014-2019)
Figure Central Nervous System Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Central Nervous System Drugs Price (2014-2019) (USD/Unit)
Table Central Nervous System Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Central Nervous System Drugs Product Type
Table Date of International Manufacturers Enter into Central Nervous System Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Central Nervous System Drugs Sales by Product (2014-2019) (K Units)
Table Global Central Nervous System Drugs Sales Share by Product (2014-2019)
Figure Global Central Nervous System Drugs Sales Market Share by Product (2014-2019)
Figure Global Central Nervous System Drugs Sales Market Share by Product in 2018
Table Global Central Nervous System Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Central Nervous System Drugs Revenue Share by Product (2014-2019)
Figure Global Central Nervous System Drugs Revenue Market Share by Product (2014-2019)
Figure Global Central Nervous System Drugs Revenue Market Share by Product in 2018
Table Central Nervous System Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Central Nervous System Drugs Sales by End User (2014-2019) (K Units)
Table Global Central Nervous System Drugs Sales Share by End User (2014-2019)
Figure Global Sales Central Nervous System Drugs Market Share by End User (2014-2019)
Figure Global Sales Central Nervous System Drugs Market Share by End User in 2018
Figure North America Central Nervous System Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Central Nervous System Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Central Nervous System Drugs Sales by Countries (2014-2019) (K Units)
Table North America Central Nervous System Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Central Nervous System Drugs Sales Market Share by Countries
Table North America Central Nervous System Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Central Nervous System Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Central Nervous System Drugs Revenue Market Share by Countries
Figure United States Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Central Nervous System Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Central Nervous System Drugs Sales by Product (2014-2019) (K Units)
Table North America Central Nervous System Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Central Nervous System Drugs Market Share by Product
Table North America Central Nervous System Drugs Sales by End User (2014-2019) (K Units)
Table North America Central Nervous System Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Central Nervous System Drugs Market Share by End User
Figure Europe Central Nervous System Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Central Nervous System Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Central Nervous System Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Central Nervous System Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Central Nervous System Drugs Sales Market Share by Countries
Table Europe Central Nervous System Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Central Nervous System Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Central Nervous System Drugs Revenue Market Share by Countries
Figure Germany Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Central Nervous System Drugs Sales by Product (2014-2019) (K Units)
Table Europe Central Nervous System Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Central Nervous System Drugs Market Share by Product
Table Europe Central Nervous System Drugs Sales by End User (2014-2019) (K Units)
Table Europe Central Nervous System Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Central Nervous System Drugs Market Share by End User
Figure Asia Pacific Central Nervous System Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Central Nervous System Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Central Nervous System Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Central Nervous System Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Central Nervous System Drugs Sales Market Share by Countries
Table Asia Pacific Central Nervous System Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Central Nervous System Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Central Nervous System Drugs Revenue Market Share by Countries
Figure China Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Central Nervous System Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Central Nervous System Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Central Nervous System Drugs Market Share by Product
Table Asia Pacific Central Nervous System Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Central Nervous System Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Central Nervous System Drugs Market Share by End User
Figure Central & South America Central Nervous System Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Central Nervous System Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Central Nervous System Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Central Nervous System Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Central Nervous System Drugs Sales Market Share by Countries
Table Central & South America Central Nervous System Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Central Nervous System Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Central Nervous System Drugs Revenue Market Share by Countries
Figure Brazil Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Central Nervous System Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Central Nervous System Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Central Nervous System Drugs Market Share by Product
Table Central & South America Central Nervous System Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Central Nervous System Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Central Nervous System Drugs Market Share by End User
Figure Middle East and Africa Central Nervous System Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Central Nervous System Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Central Nervous System Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Central Nervous System Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Central Nervous System Drugs Sales Market Share by Countries
Table Middle East and Africa Central Nervous System Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Central Nervous System Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Central Nervous System Drugs Revenue Market Share by Countries
Figure GCC Countries Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Central Nervous System Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Central Nervous System Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Central Nervous System Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Central Nervous System Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Central Nervous System Drugs Market Share by Product
Table Middle East and Africa Central Nervous System Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Central Nervous System Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Central Nervous System Drugs Market Share by End User
Table Biogen Company Details
Table Biogen Central Nervous System Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Recent Development
Table Pfizer Company Details
Table Pfizer Central Nervous System Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Teva Company Details
Table Teva Central Nervous System Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Recent Development
Table Novartis Company Details
Table Novartis Central Nervous System Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Central Nervous System Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Central Nervous System Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Otsuka Company Details
Table Otsuka Central Nervous System Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Otsuka Recent Development
Table Merck Company Details
Table Merck Central Nervous System Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Central Nervous System Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Novartis Company Details
Table Novartis Central Nervous System Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Shire Company Details
Table Global Central Nervous System Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Central Nervous System Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Central Nervous System Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Central Nervous System Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Central Nervous System Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Central Nervous System Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Central Nervous System Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Central Nervous System Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Central Nervous System Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Central Nervous System Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Central Nervous System Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Central Nervous System Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Central Nervous System Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Central Nervous System Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Central Nervous System Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Central Nervous System Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Central Nervous System Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Central Nervous System Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Central Nervous System Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Central Nervous System Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Central Nervous System Drugs Value Chain
Table Central Nervous System Drugs Customers List
Table Central Nervous System Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
中枢神経系疾患治療法の世界市場：市場規模・現状・予測 Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Depression is the dominated market of CNS Disorders Therapeutics In 2018, the global Central Nervous System Disorders Therapeutics mark…- タイサブリ薬の世界市場：インサイト・予測 Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this con…
- 泌尿生殖器薬の世界市場：インサイト・予測 A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases.The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of pi…
- HIV薬の世界市場：インサイト・予測 HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.One …
- アトピー性皮膚炎薬の世界市場：インサイト・予測 Atopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy (an adult-onset variant is recognized).One of the major factors responsible for the growing risk of severe atopic dermatitis in infancy is related to food sensitization, which is commonly associated w…